{
    "clinical_study": {
        "@rank": "13231", 
        "arm_group": {
            "arm_group_label": "Gastrocrom", 
            "arm_group_type": "Experimental", 
            "description": "4 ingestions (at 2h intervals) of a 200 mL of a 1mg/mL solution of cromolyn sodium"
        }, 
        "brief_summary": {
            "textblock": "The overall purpose of this project is to develop and validate a simple, non-invasive method\n      to detect aspiration of gastro-intestinal fluid into the respiratory tract. The\n      investigators will compare the quantity of cromolyn detected in urine collected overnight\n      after 4 ingestions (at 2h intervals) of a 200 mL of a 1mg/mL solution of cromolyn sodium, by\n      5 healthy control subjects and 10 patients (3-6 with pulmonary fibrosis; and 3-6 either\n      awaiting or recently undergone lung transplantation) with clinical and laboratory evidence\n      of GER (gastroesophageal reflux) with microaspiration."
        }, 
        "brief_title": "Cromolyn Detection of Silent Aspiration", 
        "condition": [
            "Gastroesophageal Reflux", 
            "Respiratory Aspiration", 
            "Idiopathic Pulmonary Fibrosis", 
            "Lung Transplantation"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Aspiration", 
                "Fibrosis", 
                "Gastroesophageal Reflux", 
                "Pulmonary Fibrosis", 
                "Idiopathic Pulmonary Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Healthy participants\n\n          -  Adult non-smokers\n\n          -  Females only - negative urine pregnancy test\n\n        Lung transplant patients\n\n          -  Adult patients awaiting (or recently undergone) - lung transplant\n\n          -  Evidence of gastro-esophageal reflux with probable recurrent aspiration\n\n          -  Females only - negative urine pregnancy test\n\n        Idiopathic pulmonary fibrosis patients\n\n          -  Adult patients currently enrolled in on-going University of California, San Francisco\n             study of prevalence of recurrent GER with aspiration in idiopathic pulmonary fibrosis\n\n          -  Evidence of gastro-esophageal reflux with probable recurrent aspiration\n\n          -  Females only - negative urine pregnancy test\n\n        Exclusion criteria:\n\n        Healthy participants\n\n          -  History of dysphagia\n\n          -  GER\n\n          -  Recurrent cough\n\n          -  Asthma\n\n          -  Pneumonia after childhood\n\n          -  Sleep impairment\n\n          -  Use of drugs or alcohol impairing consciousness\n\n          -  Impaired gag reflex on physical examination\n\n          -  Any other significant medical illness (e.g., morbid obesity, diabetes, neurologic\n             disease, etc.) that in the opinion of the investigator could affect the clinical\n             features measured, responses to the therapies to be given in this study, or risks of\n             participating in the study\n\n          -  Greater than 5 pack years lifetime smoking history\n\n          -  History of intolerance or allergy to cromolyn sodium\n\n        Lung transplant patients\n\n          -  History of intolerance or allergy to cromolyn sodium\n\n          -  History of Nissen fundoplication\n\n        IPF patients\n\n          -  History of intolerance or allergy to cromolyn sodium\n\n          -  History of Nissen fundoplication"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01841307", 
            "org_study_id": "13-11080"
        }, 
        "intervention": {
            "arm_group_label": "Gastrocrom", 
            "intervention_name": "Cromolyn Sodium", 
            "intervention_type": "Drug", 
            "other_name": "Gastrocrom"
        }, 
        "intervention_browse": {
            "mesh_term": "Cromolyn Sodium"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "San Francisco", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94143"
                }, 
                "name": "UCSF Airway Clinical Research Center"
            }, 
            "investigator": {
                "last_name": "Joyce Lee, MD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Development and Validation of Test for Gastro-esophageal Reflux and Aspiration", 
        "overall_contact": {
            "email": "kelsey.wollen@ucsf.edu", 
            "last_name": "Kelsey Wollen", 
            "phone": "415-514-1539"
        }, 
        "overall_contact_backup": {
            "email": "kelly.norsworthy@ucsf.edu", 
            "last_name": "Kelly Norsworthy", 
            "phone": "415-502-8791"
        }, 
        "overall_official": {
            "affiliation": "University of California, San Francisco", 
            "last_name": "Homer Boushey, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Federal Government", 
                "United States: Food and Drug Administration", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Total cromolyn in urine collected overnight", 
            "safety_issue": "No", 
            "time_frame": "Collected overnight (6 hours)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01841307"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of California, San Francisco", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Aradign Corportation", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "National Heart, Lung, and Blood Institute (NHLBI)", 
                    "agency_class": "NIH"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of California, San Francisco", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}